EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Molecular Pathogenesis of Inherited Platelet Dysfunction

Agustín Rodríguez-Alén iD, Antonio Moscardó iD, José M Bastida iD, José Rivera iD

Biomolecules · 30.10.2025 · 15 (11) · 1528

DOI: 10.3390/biom15111528 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 30.10.2025. Verfasst von Agustín Rodríguez-Alén und 3 weiteren Autor:innen. Beteiligte Einrichtung: Servicio de Hematología, Hospital Universitario de Toledo, 45007 Toledo, Spain. Hauptthemen laut MEDLINE: Blood Platelets, Blood Platelet Disorders. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Salud Carlos III (ISCIII) & European Union, ISCIII & European Union- NextGeneration EU and for PRTR, ISCIII & CIBER.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inherited platelet function disorders (IPFD) are characterized by normal platelet count and morphology but impaired function due to pathogenic variants in genes encoding membrane receptors, granule constituents, or intracellular signaling proteins. Glanzmann’s thrombasthenia, the most representative IPFD, results from ITGA2B or ITGB3 mutations that disrupt the αIIbβ3 integrin complex, producing severe mucocutaneous bleeding. Advances in molecular genetics have expanded the IPFDs landscape to include defects in other platelet receptors (Glycoprotein (GP)-VI, P2Y12, and thromboxane A2[TxA2]-R), signaling mediators (RASGRP2, FERMT3, G-protein regulators, PLC, and TxA2 pathway enzymes), and granule biogenesis disorders such as Hermansky–Pudlak and Chediak–Higashi syndromes. High-throughput sequencing technologies, including long-read approaches, have greatly improved diagnostic yield and clarified genotype–phenotype correlations. Clinically, bleeding severity varies from mild to life-threatening, and management relies on antifibrinolytics, desmopressin, or platelet transfusion; recombinant activated factor VII and hematopoietic stem cell transplantation are reserved for selected cases. Emerging strategies such as gene therapy and bispecific antibodies that link platelets and coagulation factors represent promising advances toward targeted and preventive treatment. A better knowledge of the clinical features and understanding molecular pathogenesis of IPFDs not only enhances diagnostic precision and therapeutic options but also provides key insights into platelet biology, intracellular signaling, and the broader mechanisms of human hemostasis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Blood PlateletsBlood Platelet DisordersHumansMutationSignal Transduction

Stichwörter der Autor:innen

Glanzmann thrombastheniaHermansky–Pudlak syndromecongenital platelet signaling defectsinherited platelet function disordersplatelet granule deficiency

Autor:innen und Institutionen

  • Servicio de Hematología, Hospital Universitario de Toledo, 45007 Toledo, Spain.
  • Servicio de Hematología, Hospital Universitario y Politécnico La Fe, Instituto de Investigación Sanitaria La Fe, 46001 Valencia, Spain.
  • Servicio de Hematología, Complejo Asistencial Universitario de Salamanca (CAUSA), Instituto de Investigación Biomédica de Salamanca (IBSAL), Universidad de Salamanca (USAL), 37008 Salamanca, Spain.
  • Servicio de Hematología, Hospital Universitario Morales Meseguer, Centro Regional de Hemodonación, Universidad de Murcia, IMIB-Pascual Parrilla, CIBERER-ISCIII, 30003 Murcia, Spain.

ORCID-Profile: Agustín Rodríguez-Alén, Antonio Moscardó, José M Bastida, José Rivera

Förderung

  • Instituto de Salud Carlos III (ISCIII) & European Union
  • ISCIII & European Union- NextGeneration EU and for PRTR
  • ISCIII & CIBER
  • Fundación Séneca - Agencia de Ciencia y Tecnología de la Región de Murcia
  • Gerencia Regional de Salud
  • Sociedad Española de Trombosis y Hemostasia (SETH)
  • Instituto de Salud Carlos III (ISCIII) & Feder
  • ISCIII & European Union-NextGeneration EU and for PRTR

Zitieren

APA

Rodríguez-Alén, A., Moscardó, A., Bastida, J. M., & Rivera, J. (2025). Molecular Pathogenesis of Inherited Platelet Dysfunction. Biomolecules, 15(11), 1528. https://doi.org/10.3390/biom15111528

Vancouver

Rodríguez-Alén A, Moscardó A, Bastida JM, Rivera J. Molecular Pathogenesis of Inherited Platelet Dysfunction. Biomolecules. 2025;15(11):1528. doi:10.3390/biom15111528

BibTeX
@article{RodrguezAln2025,
  author = {Rodríguez-Alén, Agustín and Moscardó, Antonio and Bastida, José M and Rivera, José},
  title = {Molecular Pathogenesis of Inherited Platelet Dysfunction},
  journal = {Biomolecules},
  year = {2025},
  volume = {15},
  number = {11},
  pages = {1528},
  doi = {10.3390/biom15111528}
}
Kostenlos starten →